Search

everythinglearnresearchcommunity

for

Search:↓

Mutations at Val-889 and Arg-752 disrupt key interactions in the androgen receptor, affecting its function.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

The document doesn't provide enough information to summarize.

The author clarified that Alopecia Areata Incognita (AAI) and diffuse Alopecia Areata (AA) are different conditions and the case discussed was actually AA, not AAI.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

The document's conclusion cannot be provided because the content is not available.

Immune cells and plasma proteins are linked to hair loss, suggesting new treatment options.

Certain gene variations may increase the risk and severity of alopecia areata.

AR-27 E-Chol siRNA can effectively regrow hair by reducing androgen receptor gene activity.

DNA analysis can help tailor alopecia treatment.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

5-ARI therapy may help prevent prostate cancer progression.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.

Key genes and pathways improve wool quality in Zhexi Angora rabbits.

The correction does not change the study's main findings.

A certain gene variation can affect protein production and is linked to male pattern baldness.

Belatacept may be a promising treatment for alopecia areata.

Aire mutation reduces alopecia areata, while Notch4 mutation prevents it in mice.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Early intervention in patch-type alopecia may prevent progression to more severe forms by targeting immune pathways and preserving keratin.

The QuantAnts machines can find cancer markers and create CRISPR targets for them.